Application no. and date | 15797762.0 (espacenet) (Federated) (European Patent Register), 20151110 | Patent/reg. no. and date | DK/EP 3218489, 20191009 | Publication date | 20170920 | Priority no. and date | US 201462077672 P, 20141110, US 201462077799 P, 20141110, US 201562137464 P, 20150324 | EP pub. no. and date |
EP 3218489 20170920 | Effective date | | Applicant/owner | Alnylam Pharmaceuticals, Inc., 675 West Kendall Street Henri A. Termeer Square
Cambridge, MA 02142, US | Applicant ref. no. | SH/GP/159681 | Inventor | RAJEEV, Kallanthottathil, G., 300 Third Street 3rd Floor
Cambridge, MA 02142, US, MANOHARAN, Muthiah, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, MILSTEIN, Stuart, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, MAIER, Martin, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, HINKLE, Gregory, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, JADHAV, Vasant, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, SEPP-LORENZINO, Laura, 300 Third Street 3rd Floor
Cambridge, MA 02142, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/713 (2006.01) , C12N 15/113 (2010.01) | Title | Hepatitis-B-virus (HBV)-IRNA-sammensætninger og fremgangsmåder til anvendelse deraf | Int. application no. | US2015059916 | Int. publication no. | WO2016077321 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|